|
|
actin filament based movement
|
GO:0030048 |
23 |
0.905
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.877
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.862
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.857
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.841
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.822
|
|
|
|
regulation of cardiac muscle contraction by calcium ion signaling
|
GO:0010882 |
9 |
0.790
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.773
|
|
|
|
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0014808 |
12 |
0.769
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.768
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.754
|
|
|
|
endoplasmic reticulum to cytosol transport
|
GO:1903513 |
12 |
0.750
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.708
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.708
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.668
|
|
|
|
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0010880 |
10 |
0.661
|
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.657
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.628
|
|
|
|
calcium ion transport from endoplasmic reticulum to cytosol
|
GO:1903514 |
12 |
0.623
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.608
|
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.607
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.605
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.570
|
|
|
|
regulation of atp catabolic process
|
GO:1903289 |
9 |
0.548
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.537
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.493
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.488
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.467
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.459
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.451
|
|
|
|
skeletal muscle adaptation
|
GO:0043501 |
16 |
0.444
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.427
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.418
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.415
|
|
|
|
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
|
GO:0010881 |
7 |
0.409
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.407
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.398
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.382
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.370
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.368
|
|
|
|
regulation of atp metabolic process
|
GO:1903578 |
17 |
0.359
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.357
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.356
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.333
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.322
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.320
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.316
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.306
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.305
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.302
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.293
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.292
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.290
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.280
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.279
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.273
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.272
|
|
|
|
positive regulation of atpase activity
|
GO:0032781 |
3 |
0.262
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.256
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.250
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.244
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.244
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.241
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.240
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.237
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.237
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.233
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.233
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.232
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.229
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.227
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.224
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.224
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.216
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.214
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.213
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.211
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.210
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.207
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.204
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.204
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.203
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.201
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.196
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.196
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.189
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.186
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.183
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.182
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.182
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.180
|
|
|
|
cell communication involved in cardiac conduction
|
GO:0086065 |
9 |
0.179
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.177
|
|
|
|
muscle filament sliding
|
GO:0030049 |
1 |
0.174
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.174
|
|
|
|
positive regulation of cardiac muscle contraction
|
GO:0060452 |
2 |
0.172
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.170
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.165
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.163
|
|
|
|
positive regulation of transmembrane transport
|
GO:0034764 |
29 |
0.162
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.159
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.159
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.158
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.157
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.156
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.156
|
|
|
|
transition between fast and slow fiber
|
GO:0014883 |
9 |
0.155
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.154
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.151
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.150
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.150
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.149
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.149
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.148
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.147
|
|
|
|
actin myosin filament sliding
|
GO:0033275 |
1 |
0.145
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.145
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.144
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.142
|
|
|
|
regulation of calcium ion transmembrane transporter activity
|
GO:1901019 |
20 |
0.140
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.139
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.139
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.134
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.132
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.132
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.131
|
|
|
|
positive regulation of ryanodine sensitive calcium release channel activity
|
GO:0060316 |
1 |
0.131
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.130
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.130
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.129
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.126
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.125
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.125
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.124
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.123
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.123
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.123
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.122
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.122
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.122
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.121
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.120
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.119
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.119
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.118
|
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.118
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.117
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.115
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.113
|
|
|
|
lung pattern specification process
|
GO:0060432 |
1 |
0.112
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.111
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.108
|
|
|
|
membrane depolarization during sa node cell action potential
|
GO:0086046 |
2 |
0.107
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.106
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.106
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.105
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.104
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.104
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.103
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.102
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.101
|
|
|
|
negative regulation of potassium ion transmembrane transporter activity
|
GO:1901017 |
3 |
0.101
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.100
|
|
|
|
positive regulation of ion transmembrane transporter activity
|
GO:0032414 |
15 |
0.100
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.099
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.098
|
|
|
|
calcium mediated signaling using intracellular calcium source
|
GO:0035584 |
3 |
0.098
|
|
|
|
positive regulation of calcium ion transmembrane transporter activity
|
GO:1901021 |
8 |
0.097
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.097
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.096
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.095
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.095
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.095
|
|
|
|
regulation of relaxation of muscle
|
GO:1901077 |
8 |
0.094
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.094
|
|
|
|
regulation of calcium ion transmembrane transport
|
GO:1903169 |
20 |
0.094
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.093
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.091
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.090
|
|
|
|
cardiac muscle cell action potential
|
GO:0086001 |
11 |
0.087
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.087
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.087
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.086
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.085
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.084
|
|
|
|
regulation of cation channel activity
|
GO:2001257 |
22 |
0.082
|
|
|
|
cardiac conduction
|
GO:0061337 |
17 |
0.082
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.081
|
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.081
|
|
|
|
regulation of potassium ion transmembrane transporter activity
|
GO:1901016 |
7 |
0.078
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.077
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.077
|
|
|
|
regulation of skeletal muscle contraction
|
GO:0014819 |
3 |
0.075
|
Mouse |
|
|
regulation of atpase activity
|
GO:0043462 |
9 |
0.075
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.075
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.075
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.074
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.074
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.073
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.072
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.072
|
|
|
|
regulation of skeletal muscle adaptation
|
GO:0014733 |
12 |
0.069
|
|
|
|
male genitalia morphogenesis
|
GO:0048808 |
4 |
0.069
|
|
|
|
skeletal muscle myosin thick filament assembly
|
GO:0030241 |
1 |
0.068
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.068
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.068
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.067
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.065
|
|
|
|
eating behavior
|
GO:0042755 |
15 |
0.065
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.064
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.064
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.063
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.063
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.063
|
|
|
|
cardiac muscle cell action potential involved in contraction
|
GO:0086002 |
6 |
0.063
|
|
|
|
regulation of high voltage gated calcium channel activity
|
GO:1901841 |
2 |
0.063
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.062
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.061
|
|
|
|
positive regulation of striated muscle contraction
|
GO:0045989 |
3 |
0.060
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.060
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.059
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.058
|
|
|
|
regulation of cardiac muscle cell contraction
|
GO:0086004 |
11 |
0.058
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.056
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.056
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.056
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.055
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.055
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.055
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.054
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.053
|
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
4 |
0.053
|
|
|
|
positive regulation of high voltage gated calcium channel activity
|
GO:1901843 |
1 |
0.053
|
|
|
|
regulation of potassium ion transmembrane transport
|
GO:1901379 |
11 |
0.053
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.052
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.052
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.052
|
|
|
|
regulation of heart rate by chemical signal
|
GO:0003062 |
4 |
0.052
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.051
|
|
|
|
positive regulation of potassium ion transmembrane transport
|
GO:1901381 |
3 |
0.051
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.051
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.050
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.050
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.050
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.050
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.050
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.049
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.049
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.049
|
|
|
|
positive regulation of atp catabolic process
|
GO:1903291 |
3 |
0.048
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.048
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.048
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.047
|
|
|
|
vascular smooth muscle contraction
|
GO:0014829 |
5 |
0.047
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.047
|
|
|
|
positive regulation of white fat cell proliferation
|
GO:0070352 |
1 |
0.047
|
|
|
|
regulation of resting membrane potential
|
GO:0060075 |
3 |
0.046
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.046
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.046
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.045
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.044
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.043
|
|
|
|
protein localization to cell junction
|
GO:1902414 |
3 |
0.043
|
|
|
|
female genitalia morphogenesis
|
GO:0048807 |
3 |
0.042
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.042
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.042
|
|
|
|
male anatomical structure morphogenesis
|
GO:0090598 |
4 |
0.042
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.042
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.041
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.041
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.041
|
|
|
|
regulation of ryanodine sensitive calcium release channel activity
|
GO:0060314 |
10 |
0.041
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.040
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.040
|
|
|
|
adrenergic receptor signaling pathway
|
GO:0071875 |
13 |
0.040
|
|
|
|
regulation of calcium transporting atpase activity
|
GO:1901894 |
2 |
0.040
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.040
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.039
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.039
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.039
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.039
|
|
|
|
directional locomotion
|
GO:0033058 |
3 |
0.039
|
|
|
|
regulation of inward rectifier potassium channel activity
|
GO:1901979 |
1 |
0.038
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.038
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.038
|
|
|
|
positive regulation of muscle contraction
|
GO:0045933 |
10 |
0.038
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.038
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.038
|
|
|
|
regulation of membrane depolarization
|
GO:0003254 |
11 |
0.038
|
|
|
|
cell cell signaling involved in cardiac conduction
|
GO:0086019 |
6 |
0.037
|
|
|
|
lung proximal distal axis specification
|
GO:0061115 |
1 |
0.037
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.036
|
|
|
|
positive regulation of heart contraction
|
GO:0045823 |
14 |
0.036
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.036
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.035
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.035
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.034
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.034
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.034
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.034
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.033
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.032
|
|
|
|
ossification involved in bone maturation
|
GO:0043931 |
12 |
0.032
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.032
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.032
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.032
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.031
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.031
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.031
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.031
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.031
|
|
|
|
semicircular canal formation
|
GO:0060876 |
1 |
0.031
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.031
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.031
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.031
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.030
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.030
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.030
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.030
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.030
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.029
|
|
|
|
regulation of potassium ion transport
|
GO:0043266 |
16 |
0.029
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.029
|
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.029
|
|
|
|
embryonic genitalia morphogenesis
|
GO:0030538 |
4 |
0.029
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.029
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.029
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.029
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.029
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.029
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.029
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.029
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.029
|
|
|
|
regulation of white fat cell proliferation
|
GO:0070350 |
2 |
0.028
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.028
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.028
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.028
|
|
|
|
positive regulation of calcium transporting atpase activity
|
GO:1901896 |
1 |
0.028
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.028
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.028
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.028
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.028
|
|
|
|
harderian gland development
|
GO:0070384 |
2 |
0.028
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.028
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.028
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.028
|
|
|
|
corticotropin hormone secreting cell differentiation
|
GO:0060128 |
3 |
0.027
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.027
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.027
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.027
|
|
|
|
semicircular canal fusion
|
GO:0060879 |
1 |
0.027
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.027
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.027
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.027
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.027
|
|
|
|
neuron recognition
|
GO:0008038 |
25 |
0.027
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.027
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.027
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.027
|
|
|
|
positive regulation of transporter activity
|
GO:0032411 |
17 |
0.026
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.026
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.026
|
|
|
|
bone maturation
|
GO:0070977 |
13 |
0.026
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.026
|
|
|
|
regulation of g protein activated inward rectifier potassium channel activity
|
GO:1900128 |
1 |
0.026
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.026
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.026
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.025
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.025
|
|
|
|
response to pain
|
GO:0048265 |
26 |
0.025
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.025
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.025
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.025
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.025
|
|
|
|
positive regulation of heart rate
|
GO:0010460 |
10 |
0.025
|
|
|
|
regulation of actin filament based movement
|
GO:1903115 |
12 |
0.024
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.024
|
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
33 |
0.024
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.024
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.024
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.024
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.024
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.024
|
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.024
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.024
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.023
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.023
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.023
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.023
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.023
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.023
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.023
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.023
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.023
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.023
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.023
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.023
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.022
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.022
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.022
|
|
|
|
tubulin complex biogenesis
|
GO:0072668 |
2 |
0.022
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.022
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.022
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.022
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.022
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.022
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.022
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.021
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.021
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.021
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.021
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.021
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.021
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.021
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.021
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.021
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.021
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.021
|
|
|
|
regulation of pinocytosis
|
GO:0048548 |
1 |
0.021
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.021
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.021
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.020
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.020
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.020
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.020
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.020
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.020
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.020
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.020
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.020
|
|
|
|
intracellular distribution of mitochondria
|
GO:0048312 |
1 |
0.020
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.020
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.020
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.019
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.019
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.019
|
|
|
|
type b pancreatic cell apoptotic process
|
GO:0097050 |
6 |
0.019
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.019
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.019
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.019
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.019
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.019
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.019
|
|
|
|
fat cell proliferation
|
GO:0070341 |
4 |
0.019
|
|
|
|
deltoid tuberosity development
|
GO:0035993 |
3 |
0.019
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.019
|
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.019
|
|
|
|
positive regulation of cation channel activity
|
GO:2001259 |
8 |
0.019
|
|
|
|
response to inactivity
|
GO:0014854 |
4 |
0.019
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.018
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.018
|
|
|
|
tubulin complex assembly
|
GO:0007021 |
2 |
0.018
|
|
|
|
renal sodium ion transport
|
GO:0003096 |
2 |
0.018
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.018
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.018
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.018
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.018
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.018
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.018
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.018
|
|
|
|
white fat cell proliferation
|
GO:0070343 |
2 |
0.017
|
|
|
|
organ maturation
|
GO:0048799 |
17 |
0.017
|
|
|
|
establishment or maintenance of neuroblast polarity
|
GO:0045196 |
1 |
0.017
|
|
|
|
negative regulation of potassium ion transmembrane transport
|
GO:1901380 |
4 |
0.017
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.017
|
|
|
|
short chain fatty acid catabolic process
|
GO:0019626 |
2 |
0.017
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.017
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.017
|
|
|
|
negative regulation of anoikis
|
GO:2000811 |
2 |
0.017
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.017
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.017
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.017
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.017
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.017
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.017
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.017
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.016
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.016
|
|
|
|
l glutamate uptake involved in synaptic transmission
|
GO:0051935 |
3 |
0.016
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.016
|
|